Octagon Capital Advisors’s Pharvaris PHVS Stock Holding History

Octagon Capital Advisors’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8M	Buy	456,721 +291,721	+177%	+$8.83M	1.42%	18
2026 Q1	$4.66M	Sell	165,000 -506,465	-75%	-$13.5M	0.52%	26
2025 Q4	$18.6M	Sell	671,465 -51,130	-7%	-$1.23M	2.26%	19
2025 Q3	$18M	Buy	722,595 +50,000	+7%	+$1.11M	2.73%	15
2025 Q2	$11.8M	Sell	672,595 -97,220	-13%	-$1.57M	2.6%	18
2025 Q1	$12.1M	Sell	769,815 -8,185	-1%	-$138K	2.34%	17
2024 Q4	$14.9M	Buy	778,000 +157,530	+25%	+$3.24M	2.45%	17
2024 Q3	$11.5M	Buy	+620,470	New	+$11.3M	1.79%	17

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Octagon Capital Advisors's PHVS Position: Q2 2026 in Review

Octagon Capital Advisors increased its Pharvaris (PHVS) stake by 177% in Q2 2026, buying an estimated $8.83M and bringing the position to 456,721 shares worth $15.8M. The position accounts for 1.42% of the portfolio, ranked #18.

Octagon Capital Advisors first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $18.6M in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

Octagon Capital Advisors held 456,721 shares of Pharvaris worth $15.8M as of Q2 2026.
Octagon Capital Advisors bought 291,721 Pharvaris shares in Q2 2026, an estimated $8.83M.
Pharvaris made up 1.42% of Octagon Capital Advisors's portfolio in Q2 2026, its #18 holding.
Octagon Capital Advisors first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
Octagon Capital Advisors's Pharvaris position peaked at $18.6M in Q4 2025.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Octagon Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.